as on September 15, 2025 at 8:38 pm IST
Day's Low
Day's High
1.58%
Downside
1.93%
Upside
52 Week's Low
52 Week's High
52.90%
Downside
198.77%
Upside
Check Replimune Group Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$447.3M
EPS (TTM)
-2.8128
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0P/B Ratio
0PEG Ratio
0EBITDA
-287.2M
Revenue (TTM)
-
Profit Margin
0.00%
Return On Equity TTM
6123800.00%
Compare market cap, revenue, PE, and other key metrics of Replimune Group Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
BUY | $447.3M | -76.05% | NA | 0.00% | |
BUY | $61.1B | 256.98% | -505.15 | -12.96% | |
NA | $38.7B | NA | NA | -3.89% | |
BUY | $101.1B | 47.85% | 28.07 | 31.86% | |
BUY | $59.4B | -3.43% | 14.11 | 31.37% |
The Replimune Group Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Replimune Group Inc investment value today
Current value as on today
₹56,108
Returns
Returns from Replimune Group Inc Stock
Dollar Returns*
₹4,985 (+4.99%)
Based on 15 analysts
93.33%
Buy
6.67%
Hold
0.00%
Sell
Based on 15 analysts, 93.33% of analysts recommend a 'BUY' rating for Replimune Group Inc. Average target price of $4.86
Get share price movements and forecasts by analysts on Replimune Group Inc.
What analysts predicted
-17.08%DOWNSIDE
Target Price
$4.86
Current Price
$5.69
Analyzed by
15 Analysts
Target
$4.86
Replimune Group Inc target price $4.86, a slight downside of -17.08% compared to current price of $5.69. According to 15 analysts rating.
Search interest for Replimune Group Inc Stock has decreased by -91% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Profit Spike
Netprofit is up for the last 2 quarters, 1.73 Cr → 2.49 Cr (in ₹), with an average increase of 30.5% per quarter
Retail Holding Up
Retail Investor have increased holdings from 31.32% to 31.34% in Jun 2025 quarter
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 123.5% return, outperforming this stock by 190.6%
Against Peers
In the last 1 year, One 97 Communications Ltd has given 78.7% return, outperforming this stock by 105.9%
Promoter Holding Unchanged
Promoters holdings remained unchanged at 68.55% of holdings in Jun 2025 quarter
Against Peers
In the last 3 years, Firstsource Solutions Ltd has given 225.9% return, outperforming this stock by 236.9%
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 75.6% return, outperforming this stock by 124.1%
Price Dip
In the last 7 days, REPL stock has moved down by -4.3%
Price Dip
In the last 7 days, REPL stock has moved down by -5.1%
Revenue Fall
Revenue is down for the last 2 quarters, 37.13 Cr → 20.08 Cr (in ₹), with an average decrease of 45.9% per quarter
Organisation | Replimune Group Inc |
Headquarters | 500 Unicorn Park Drive, Woburn, MA, United States, 01801 |
Industry | Health Technology |
CEO | Dr. Sushil Patel Ph.D. |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Mr. Camilo Garcia M.A., M.B.A. | Chief Human Resource Officer |
Mr. Christopher Sarchi | Chief Commercial Officer |
Mr. Paul Bullock | Chief Manufacturing Officer & Framingham Site Head |
Dr. Sushil Patel Ph.D. | CEO & Director |
Ms. Emily Luisa Hill | Chief Financial Officer |
Dr. Konstantinos Xynos M.B.A., M.D., Ph.D. | Chief Medical Officer |
Mr. Philip Astley-Sparke F.S.A. | Executive Chairman |
Mr. Andrew Schwendenman | Chief Accounting Officer & Treasurer |
Mr. Shawn Glidden J.D. | Senior VP & General Counsel |
Ms. Nina Aragam | Senior Vice President of Portfolio Strategy & Program Management |
Replimune Group Inc share price today is $5.69 as on . Replimune Group Inc share today touched a day high of $5.8 and a low of $5.6.
Replimune Group Inc share touched a 52 week high of $17 on and a 52 week low of $2.68 on . Replimune Group Inc stock price today i.e. is trending at $5.69,which is 66.53% down from its 52 week high and 112.31% up from its 52 week low.
Replimune Group Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Replimune Group Inc (REPL) shares with as little as ₹88.141 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹881.41 in Replimune Group Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Replimune Group Inc share’s latest price of $5.69 as on September 15, 2025 at 8:38 pm IST, you will get 1.7575 shares of Replimune Group Inc. Learn more about
fractional shares .
Replimune Group Inc stock has given -76.05% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?